Method for carrying out solvent-out crystallization on allopurinol
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHONGQING KANGLE PHARMA
- Publication Date
- 2015-03-25
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention belongs to the technical fields of medicine and chemical industry, and in particular relates to a method for dissolution and crystallization of allopurinol. Background technique
[0002] Allopurinol is also known as allopurinol, aropurine, allopurinol, cyloryl, hydroxypyrazole pyrimidine, the English name is Allopurinol, and the chemical name is 1H-pyrazolo[3,4-d]pyrimidine-4 -alcohol, the chemical structural formula is as follows:
[0003]
[0004] Allopurinol is a xanthine oxidase inhibitor, suitable for various diseases with primary or secondary serum uric acid increase, such as gout, acute or chronic leukemia, polycythemia vera, multiple myeloma and other malignant Hyperuricemia caused by massive necrosis of tumor cells during chemotherapy or radiotherapy can prevent and treat urate nephropathy, etc., with remarkable curative effect and minimal side effects, so it is widely used clinically.
[0005] The preparation method of the ...